| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/07/2002 | WO2002018657A1 Haplotypes of the or11a1 gene |
| 03/07/2002 | WO2002018656A2 Method for analysis of oligonucleotide analogs |
| 03/07/2002 | WO2002018655A2 Compositions and methods for the generation of single stranded cdna microarrays with accurate universal quantitation reference |
| 03/07/2002 | WO2002018654A1 Induction of ldl receptor expression by extracellular-signal regulated kinase, erk-1/2 |
| 03/07/2002 | WO2002018652A2 Method for detection of htr and htert telomerase-associated rna in plasma or serum |
| 03/07/2002 | WO2002018651A2 Methods for detecting papillomavirus dna in blood plasma and serum |
| 03/07/2002 | WO2002018650A1 Diagnostic markers for multiple epilepsy phenotypes |
| 03/07/2002 | WO2002018649A1 Nested methylation-specific polymerase chain reaction cancer detection method |
| 03/07/2002 | WO2002018648A2 Analysis of binding interactions |
| 03/07/2002 | WO2002018647A1 Haplotypes of the gng7 gene |
| 03/07/2002 | WO2002018646A2 Gene discovery using microarrays |
| 03/07/2002 | WO2002018645A2 5t4 rna in plasma and serum as a marker for neoplastic disease |
| 03/07/2002 | WO2002018644A2 Mass spectrometric analysis of biopolymers |
| 03/07/2002 | WO2002018643A2 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 03/07/2002 | WO2002018642A1 Method of detecting gene |
| 03/07/2002 | WO2002018641A2 Detection of cyp3a4 and cyp2c9 polymorphisms |
| 03/07/2002 | WO2002018640A2 Gene called aladin, involved in allgrove syndrome, its expression product and their applications |
| 03/07/2002 | WO2002018639A2 Detection of cyp2c19 polymorphisms |
| 03/07/2002 | WO2002018638A2 Detection of cyp2d6 polymorphisms |
| 03/07/2002 | WO2002018637A2 Diagnosis and treatment of prostate cancer |
| 03/07/2002 | WO2002018636A2 Improvements in and relating to marking using dna |
| 03/07/2002 | WO2002018635A2 Use of nonviable particles comprising an internal control (ic) nucleic acid |
| 03/07/2002 | WO2002018634A2 Arrays of immobilised biomolecules, production and use thereof |
| 03/07/2002 | WO2002018633A2 Determination of the ability of patients to respond to tumour treatment |
| 03/07/2002 | WO2002018632A2 Method for determining the degree of methylation of defined cytosines in genomic dna in the sequence context 5'-cpg-3' |
| 03/07/2002 | WO2002018631A2 Diagnosis of illnesses or predisposition to certain illnesses |
| 03/07/2002 | WO2002018630A2 Method of establishing resistance profiles of tissues and cell lines |
| 03/07/2002 | WO2002018629A1 Degenerate oligonucleotide gene shuffling |
| 03/07/2002 | WO2002018626A1 Modulators of the interaction between arp2/3 and cortactin or hs-1 |
| 03/07/2002 | WO2002018625A2 Compositions and methods for detecting target microorganisms in a sample |
| 03/07/2002 | WO2002018623A2 Methods and reagents for protease inhibition |
| 03/07/2002 | WO2002018622A2 TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b) |
| 03/07/2002 | WO2002018619A2 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 03/07/2002 | WO2002018616A1 Adjusting the efficiency of nucleic acid template amplification by attenuated pcr with template-mimic oligonucleotides |
| 03/07/2002 | WO2002018615A1 Methods for reducing complexity of nucleic acid samples |
| 03/07/2002 | WO2002018608A2 Methods for enhancing the efficacy of cancer therapy |
| 03/07/2002 | WO2002018603A1 Isomaltulose synthase |
| 03/07/2002 | WO2002018588A1 Method for screening highly active proteases and inhibitors |
| 03/07/2002 | WO2002018586A1 Design and construction of transcription template for synthesizing cell-free protein, and dilution batch-type method of synthesizing cell-free wheat germ protein by using the same |
| 03/07/2002 | WO2002018585A2 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | WO2002018581A2 G-protein coupled receptors |
| 03/07/2002 | WO2002018576A2 Compositions and methods relating to lung specific genes |
| 03/07/2002 | WO2002018575A2 Genes expressed in the cell cycle |
| 03/07/2002 | WO2002018572A2 Membrane penetrating peptides and uses thereof |
| 03/07/2002 | WO2002018557A2 Human kinases |
| 03/07/2002 | WO2002018554A2 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
| 03/07/2002 | WO2002018553A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | WO2002018548A2 Tyrosine hydroxylase 5' control elements and uses thereof |
| 03/07/2002 | WO2002018544A2 Method and reagents for treatment of skin disorders by modulating the notch pathway |
| 03/07/2002 | WO2002018539A2 Method for assaying the activity of lysosomal enzymes |
| 03/07/2002 | WO2002018537A2 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 03/07/2002 | WO2002018441A2 Electroprocessed fibrin-based matrices and tissues |
| 03/07/2002 | WO2002018438A1 Modified proteins, isolated novel peptides, and uses thereof |
| 03/07/2002 | WO2002018418A1 Antibodies specific for methylated lysines in histones |
| 03/07/2002 | WO2002018414A2 Haplotypes of the bf gene |
| 03/07/2002 | WO2002018413A2 Haplotypes of the scya2 gene |
| 03/07/2002 | WO2002018410A1 Haplotypes of the agtr1 gene |
| 03/07/2002 | WO2002018409A1 Antisense modulation of hpk/gck-like kinase expression |
| 03/07/2002 | WO2002018408A1 Haplotypes of the junb gene |
| 03/07/2002 | WO2002018342A2 Novel autoinducer molecules and uses therefor |
| 03/07/2002 | WO2002017949A2 Novel functions for dp214 |
| 03/07/2002 | WO2002017858A2 Role of fosb in bone formation |
| 03/07/2002 | WO2001094420B1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 03/07/2002 | WO2001090415A3 Method of producing a dna library using positional amplification |
| 03/07/2002 | WO2001090408A3 Method for detecting and characterising activity of proteins involved in lesion and dna repair |
| 03/07/2002 | WO2001088184A3 Compositions and methods for genetic analyses |
| 03/07/2002 | WO2001085915A3 Identifying clusters of transcription factor binding sites |
| 03/07/2002 | WO2001081542A3 Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data |
| 03/07/2002 | WO2001080810A9 Chondroitin synthase gene and methods of making and using same |
| 03/07/2002 | WO2001079269A3 Lipid binding protein 4 |
| 03/07/2002 | WO2001077675A3 Method for the prediction of preeclampsia and other diseases |
| 03/07/2002 | WO2001074833A3 Haplotypes of the chrnb2 gene |
| 03/07/2002 | WO2001069229A3 Method for separating, identifying and quantifying alkaline isophosphatases by electrophoresis |
| 03/07/2002 | WO2001064838A3 Thermophilic dna polymerases from thermoactinomyces vulgaris |
| 03/07/2002 | WO2001061031A3 Improved assay for protein tyrosine phosphatases |
| 03/07/2002 | WO2001059155A3 Interferon-alpha induced genes |
| 03/07/2002 | WO2001057233A3 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 03/07/2002 | WO2001056216A3 Method, system and computer software for providing a genomic web portal |
| 03/07/2002 | WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 03/07/2002 | WO2001053521A3 Oligonucleotides identifying fungicide resistant fungi |
| 03/07/2002 | WO2001053468A3 Lipid metabolism enzymes and polynucleotides encoding them |
| 03/07/2002 | WO2001051650A3 Methods for determining the presence or absence of microorganisms in lipid-containing compositions |
| 03/07/2002 | WO2001051636A3 Secreted proteins |
| 03/07/2002 | WO2001046231A3 Polynucleotides and polypeptides encoded thereby |
| 03/07/2002 | WO2001042285A3 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 03/07/2002 | WO2001040474A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/07/2002 | WO2001037194A3 Crystallizable compositions comprising a caspase-7 |
| 03/07/2002 | WO2001036686A3 Genomic polymorphism for predicting therapeutic response |
| 03/07/2002 | WO2001032915A3 Reversed-phase hplc assay for plasminogen activators |
| 03/07/2002 | WO2001032888A3 Human transferase molecules |
| 03/07/2002 | WO2001031008A3 Human and rat fgf-20 genes and gene expression products |
| 03/07/2002 | WO2001031006A3 Serum amyloid a isoform from colostrum |
| 03/07/2002 | WO2001029220A3 Mage-a12 antigenic peptides and uses thereof |
| 03/07/2002 | WO2001021772A3 Methods and microorganisms for production of panto-compounds |
| 03/07/2002 | WO2001021654A3 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/07/2002 | WO2001011086A3 Methods of screening for angiogenesis modulators |
| 03/07/2002 | WO2001007915A8 Layered device with capture regions for cellular analysis |
| 03/07/2002 | WO2000073503A9 Use of the combing process for the identification of dna origins of replication |
| 03/07/2002 | WO2000056352A3 Reagents and methods useful for detecting diseases of the prostate |
| 03/07/2002 | US20020029113 Method and system for predicting splice variant from DNA chip expression data |